Treatment of neuronal degeneration with 5HT1.sub.A agonists
US5162375A · kind A · utility
28Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 28, 1991 |
| Grant date | Nov 10, 1992 |
| Priority date | — |
| Expiry date | Feb 28, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for the treatment and/or prophylaxis of disorders associated with neuronal degeneration resulting from ischaemic events, in mammals, such as humans, which comprises administering to the mammal in need of such treatment an effective amount of a 5-HT1.sub.A agonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.